Top Markets
Coin of the day
Spectral Medical Inc. Spectral Medical Inc.

Spectral Medical Inc.

EDT
Classement en actions #16678
Spectral Medical Inc. focuses on the development and commercialization of... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Prix de l'action
$0.95411796
Dernière synchronisation: 2026-09-01
Capitalisation boursière
$279.96M
Changement (1 jour)
-0.76%
Changement (1 an)
-16.23%
Pays
CA
Échange Spectral Medical Inc. (EDT)

Catégorie

Ratio P/B pour Spectral Medical Inc. (EDT)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Spectral Medical Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Spectral Medical Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
4.346 -
US
2.8646 -
US
- -
CN
25.3254 -
US
27.6506 -
US